numinus

Payton Nyquvest Shares MAPS’ Phase 3 PTSD Results

Sep 15, 2023

TDR’s Top 5 Psychedelic Developments For The Week Of August 21

Aug 26, 2023

Numinus CEO Expects MAPS Phase 3 MDMA-Assisted Therapy Readout To Galvanize The Sector

Aug 23, 2023

Nyquvest on Numinus MDMA Therapy Prospects

Jul 20, 2023

Numinus Reports Q2 2023 Financial Results, Registers Double-Digit Sequential Revenue Growth

Jul 17, 2023

TDR’s Top 5 Psychedelic Developments For The Week Of June 12

Jun 17, 2023

Numinus’ Clinical Site Joins Compass’ Phase 3 Program On Psilocybin Therapy For TRD

May 31, 2023

TDR’s Top 5 Psychedelic Developments For The Week Of May 22

May 27, 2023

Numinus CEO Outlines MDMA Assisted-Therapy Strategy; Believes MAPS Phase 3 Data Coming Soon

May 25, 2023

Numinus CEO Payton Nyquvest On Q2 2023 Financial Results And Numinus Network

Apr 18, 2023